A South Florida clinic that promotes controversial stem-cell treatments for a wide range of ailments is among the centers receiving a written warning that it is violating federal public health laws.
The U.S Food and Drug Administrations letter was addressed to Dr. Thomas A. Gionis, owner and chief surgeon of the Miami Stem Cell Treatment Center located in Boca Raton. Gionis also owns a stem cell treatment center in Irvine, Calif.
The letter shows that a third Gionis clinic in New York City apparently closed after FDA inspections of all three clinics was carried out from July through September 2015.
Dr. Gionis facilities are among more than 170 clinics across the country that are selling experimental stem cell procedures for dozens of diseases and conditions a mushrooming industry that has flourished despite little evidence of its safety or effectiveness.
Descriptions on the website say that Dr. Gionis and other practitioners inject or infuse a liquid that is said to contain stem cells derived from the patients own fat tissue, removed through liposuction. The clinic lists a large number of illnesses for which it says the treatments are appropriate, including: heart and lung disease, stroke, multiple sclerosis, spinal disc disease and auto-immune problems like lupus.
And his clinics are not the only ones operating in Florida. Internet search indicates this type of stem-cell treatment is available at clinics in Jacksonville, Orlando, St. Petersburg, Sunrise and a number of other sites throughout the state.
The rise of the U.S. stem cell industry illustrates how quickly fringe medicine can outpace government oversight. Over the last five years, academic stem cell researchers say they have watched in dismay as doctors treat patients with experimental techniques that they say could take years, if not decades, to become sound medicine.
"It's sort of this 21st century cutting-edge technology. But the way it's being implemented at these clinics and how it's regulated is more like the 19th century. It's a Wild West," says Dr. Paul Knoepfler, a stem cell researcher at the University of California at Davis.
The FDA letter to Dr. Gionis, dated Dec. 30, provides some insight into how the FDA is addressing the issue. In difficult-to-parse language, it says that the substance that Gionis is processing and injecting amounts to a drug that has not been approved for safety and usefulness.
The writer, Mary Malarkey, director of an office in the FDAs Center for Biologics and Research, says that if Gionis maintains his treatments are part of a clinical trial, as his website suggests, he would need to submit an Investigational New Drug (IND) application to FDA.
The FDA official says an earlier defense by the clinic that the chemical used in the mixture has been changed doesnt make it acceptable without more information.
Health News Florida was not able to reach Dr. Gionis on Monday, but left a message with his staff.
The Associated Press reported last May that entrepreneurial ventures using fat-derived stem cells have proliferated throughout the country. Scientists engaged in authorized stem-cell research said states have not stepped up to regulate the ventures and called on FDA to do so.
The FDA has scheduled a public hearing for April on draft guidelines for fat-derived stem-cell treatments that the agency released a few months ago. That led some to mistakenly think the treatments are being subjected to new regulations, said FDA spokeswoman Sarah Peddicord. She said the regulations went into effect in 2005.
The law has not changed, she said. What the agency released are guidelines that FDA hopes will help the industry and the public understand the law.
People need to understand how to implement the regulations, she said. The guidelines are just to explain the regulations.
Stem cells have long been recognized for their ability to reproduce and regenerate tissue. And while there are high hopes that they will someday be used to treat a range of debilitating diseases, critics say stem cell entrepreneurs have little more than anecdotes to support their offerings.
In 2010, there were only a handful of doctors promoting stem cell procedures in the U.S., mainly plastic surgeons promoting "stem cell facelifts" and other cosmetic procedures. But today there are clinics throughout the country promoting stem cells for dozens of conditions and diseases, including Alzheimer's, arthritis, erectile dysfunction and hair loss. The cost of these procedures is high, ranging from $5,000 to $20,000.
Many of the businesses are linked in large, for-profit chains which offer doctors the chance to join the franchise after taking a seminar and buying some equipment.
The largest of these chains is the Cell Surgical Network, co-founded in 2012 by Dr. Mark Berman, who spent 30 years as a Beverly Hills plastic surgeon before working with stem cells. His company offers stem cell procedures for more than 30 diseases and conditions, including Lou Gehrig's disease, multiple sclerosis and arthritis.
He and his partner adapted technology from Asia into a liposuction-based procedure in which fat is pumped out of patients' abdomen, processed with drugs and equipment and then injected back into the body.
Berman says this fat-based "soup," is rich in shape-shifting stem cells that have the potential to treat everything from neurological diseases to achy joints.
"I don't even know what's in the soup," says Berman. "Most of the time, if stem cells are in the soup, then the patient's got a good chance of getting better."
The clinics insist that their treatments are safe, but routinely require that patients sign waivers.
Patients of Dr. Zannos Grekos, a Florida cardiologist specializing in stem cell therapy, were also required to sign a consent form, acknowledging the procedures' risks, including death.
But families of two Grekos patients who died under his care say he downplayed the risks. Gina Adams, daughter of patient Richard Poling, says her family was told her father would be "back on the golf course the next day" after a procedure intended to treat a lung condition that made breathing difficult. The cost was $8,000.
In March 2012, Grekos harvested fat from Poling's abdomen and sent it to an off-site processing facility to isolate the stem cells. Later that afternoon, he directed an assistant to infuse the resulting mixture into the patient's bloodstream.
Poling suffered cardiac arrest and was pronounced dead after being rushed to a local hospital.
Two years earlier, in 2010, 69-year old Domenica Fitzgerald suffered a stroke after Grekos infused unfiltered bone marrow-derived stem cells into the arteries of her brain. The state report concluded "it was virtually inevitable that the procedure would clog blood vessels in the brain and cause a major and very possibly fatal stroke." Fitzgerald suffered severe brain damage and was removed from life support several days later.
Jack Fitzgerald says his wife, who used a wheel chair, had hoped that stem cells might help her walk again.
Not until 2013, after Poling's death, did the Florida Board of Medicine vote to revoke Grekos' license.
Though barred from practicing medicine in Florida, Grekos continues to treat patients in the Dominican Republican through his company Regenocyte, which promotes treatments for autism, dementia and many other diseases.
He believes the two deaths were unrelated to his care the state targeted him to discourage other doctors from working with stem cells, he says.
State actions against stem cell doctors are rare. That's led industry critics to conclude that regulation must come from the FDA, which regulates medical products on a national level.
But the FDA's authority to regulate stem cell procedures is not clearly defined and has been debated by legal experts for years.
Now, the FDA appears to be stepping up its oversight. In the last days of 2014, it released draft guidelines dealing with the popular fat-based stem cell technique. The agency said that processing fat to extract stem cells for medical use essentially creates a new drug, which cannot be sold in the U.S. without the agency's approval.
But many stem cell doctors continue to argue that they don't need FDA permission because they are not creating drugs, but performing in-office surgical procedures.
For now, Berman says he has no plans to change his business.
"How is it unethical if you're actually helping people, even if we don't have evidence-based studies to prove it?" he asks.
Carol Gentry is a special correspondent for WUSF in Tampa. Health News Florida receives support from the Corporation for Public Broadcasting.
Read more here:
FDA: Florida Stem Cell Clinic Violates Law | Health News ...
- Organoids: science fiction or the future of pre-clinical studies? - Lexology - October 13th, 2022
- Researchers develop method to study brain connectivity, functionality - Florida Hospital News and Healthcare Report - South Florida Hospital News - October 13th, 2022
- A win for stem cells | Washington Examiner - October 4th, 2022
- TransMedia Group to Illumine Impressive Neuro Healing Results Achieved by Raymond Cralle, a Pioneer in Hyperbaric Oxygen Therapy and a Florida... - September 16th, 2022
- Sure Signs You Have Non-Hodgkin's Lymphoma Eat This Not That - Eat This, Not That - August 22nd, 2022
- New treatment changing outlook for those with blood cancers - WBAL TV Baltimore - July 19th, 2022
- Engineering Graduate Fellows Get Hands-on Experience with National Industry Leaders - UCF - July 11th, 2022
- New Alzheimer's Treatment on Horizon as Dementia Reversed for First Time in Dogs - StreetInsider.com - June 22nd, 2022
- Life Cycle of a Moss - Infographic - STEM Lounge - June 13th, 2022
- Miller School Researchers on the Trail to Unraveling Long COVID-19 - Florida Hospital News and Healthcare Report - South Florida Hospital News - June 4th, 2022
- American Academy of Stem Cell Physicians is Proud to Add to the Speaker Roster, Dr. Scheffer Tseng, Acclaimed Opthamologist and Founder of Bio-Tissue... - May 15th, 2022
- 'Doctors gave me six months to live in 2016 but I continue to defy every expectation' - Wales Online - May 2nd, 2022
- Revolutionary Oxygen Healing Therapy Now Available in Florida - Digital Journal - March 25th, 2022
- Global Mesenchymal Stem Cells Market Analysis, Opportunities, Trend and Forecast To 2029 Discovery Sports Media - Discovery Sports Media - January 20th, 2022
- EDUCATION SPOTLIGHT: Florida Tech Highlights Work Done During 2021 as We Enter the New Year - SpaceCoastDaily.com - January 5th, 2022
- Roundtable Discussion: Shain Looks at the Role of Transplant Eligibility in Patients With Newly Diagnosed Multiple Myeloma - Targeted Oncology - November 8th, 2021
- ALS and dementia attacked by an RNA-hunting compound that recruits cell's own virus fighter - EurekAlert - October 28th, 2021
- Brainstorm Cell, (BCLI) falls 0.65% in Active Trading on October 25 - Equities.com - October 28th, 2021
- Global Mesenchymal Stem Cells Market Prospects, Upcoming Trends and Competitive Outlook till 2028 | Lonza, Thermo Fisher, Bio-Techne, ATCC,... - October 28th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - WWNY - October 5th, 2021
- US FDA Approves Kite's Tecartus as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia | DNA RNA and... - October 5th, 2021
- Times really up! FDA authority to crack down on regenerative medicines upheld as grace period ends - JD Supra - July 21st, 2021
- Animal Stem Cell Therapy Market Size, Industry Analysis, Growth Factors, Trends, and Regional Forecast to 2027 - The Courier - March 11th, 2021
- An 8-year-olds search for bone marrow match in battle with leukemia comes to North Texas - The Dallas Morning News - March 11th, 2021
- Eirion Therapeutics, Inc. Closes $40 Million Series A Investment and Licensing Deal with Shanghai Haohai Biological Technology Ltd. - PRNewswire - March 11th, 2021
- How soon will COVID-19 vaccines return life to normal? - Science Magazine - February 16th, 2021
- Keep it Flowing: Combating COVID-19 Blood Shortages in Cancer Treatment - Curetoday.com - February 16th, 2021
- FL Doctors Make Breakthrough Using Stem Cells to Treat ... - February 2nd, 2021
- This Guy Injected His Dick With Stem Cells to Try to Make ... - February 2nd, 2021
- 10 Best Stem Cell Beauty Products On The Market Today - February 2nd, 2021
- HealthLynked's The Future of Healthcare Summit Brings Healthcare Experts and Technology Innovators from Around the World to Naples, Florida -... - February 2nd, 2021
- SpaceX Cargo Dragon Returning To Earth; First U.S. Commercial Cargo Craft To Return From ISS - Science Times - January 8th, 2021
- Buoyed by study, scientists increasingly hopeful first two COVID-19 vaccines effective against new strains - The Boston Globe - January 8th, 2021
- Flavors added to vaping devices damage the heart, vanilla custard the most toxic of all - Study Finds - December 23rd, 2020
- Flavours added to vaping devices can damage the heart: Study - Sify News - December 12th, 2020
- Jabbed for a good cause: Hundreds already getting COVID-19 shots as part of clinical trial - The West Volusia Beacon - August 29th, 2020
- Hesperos demonstrates innovative Human-on-a-Chip approach to modeling innate immune system response following tissue damage and acute inflammation -... - June 8th, 2020
- Hesperos Human-on-a-Chip System Used to Model Preclinical Stages of Alzheimers Disease and Mild Cognitive Impairment - Yahoo Finance - June 4th, 2020
- Can genetics explain the degrees of misery inflicted by the coronavirus? - Genetic Literacy Project - April 21st, 2020
- Beating cancer by taking the unbeaten path | ASU Now: Access, Excellence, Impact - ASU Now - April 9th, 2020
- Reviewing CRYO-CELL International (OTCMKTS:CCEL) and Harsco (OTCMKTS:HSC) - Redmond Register - March 26th, 2020
- Head to Head Analysis: Harsco (NYSE:HSC) & CRYO-CELL International (NYSE:CCEL) - Redmond Register - March 24th, 2020
- Reviewing Harsco (NYSE:HSC) and CRYO-CELL International (NYSE:CCEL) - Redmond Register - March 12th, 2020
- Data On Enlivex's Allocetra-OTS Immunotherapy for Peritoneal Solid Tumors and for Prevention of GvHD Selected for Presentation at the Transplantation... - February 24th, 2020
- Consistent Outcomes Using Ryoncil as First-Line Treatment or Salvage Therapy in 309 Children With Steroid-Refractory Acute GVHD - BioSpace - February 24th, 2020
- NASA to send equipment to International Space Station to research Improving Shoes, Showers, 3D Printing - Clarksville Online - February 24th, 2020
- Here are all the science projects that SpaceX will deliver to the ISS - Digital Trends - February 24th, 2020
- 34 years with a new heart and counting - MDJOnline.com - February 24th, 2020
- 'Florida cold' and the semi-glamorous world of work trips - CT Insider - February 19th, 2020
- 34 Years with a New Heart and Counting | 90.1 FM WABE - WABE 90.1 FM - February 19th, 2020
- Study shows how a tiny and strange marine animal produces unlimited eggs and sperm over its lifetime - National Institutes of Health - February 16th, 2020
- Research - Florida Stem Cell Research - January 3rd, 2020
- Florida Stem Cell Treatment Center - January 3rd, 2020
- Advances In Treatment Of Soft Tissue Injuries (Video) - South Florida Reporter - January 3rd, 2020
- Explained: What is the water crisis Southwest Florida is battling? - Wink News - December 24th, 2019
- Mum shares heartbreaking photo of toddler sobbing through gruelling cancer treatment - The Sun - December 1st, 2019
- World AIDS Day 2019: Theme, History and Facts about HIV and AIDS - Newsweek - December 1st, 2019
- Tulane team researching ways to end opioid addiction - News from Tulane - November 24th, 2019
- Improve global wellbeing with a degree in public health - Study International News - November 12th, 2019
- Fate Therapeutics Announces Six Presentations at the 2019 ASH Annual Meeting - GlobeNewswire - November 12th, 2019
- Reviewing US Stem Cell (OTCMKTS:USRM) and Auxly Cannabis Group (OTCMKTS:CBWTF) - Riverton Roll - November 12th, 2019
- Bloomington Vet Joins Study For Stem Cell Therapy To Treat Dogs With Arthritis - WGLT News - October 24th, 2019
- Brooks Koepka Withdraws in Korea After Reaggravating Knee Injury - Golf Channel - October 24th, 2019
- Walking in His Shoes - Curetoday.com - October 5th, 2019
- The Real Problem With Beef - The New York Times - October 2nd, 2019
- Stem Cell Treatment Clinic St. Augustine - Florida Stem Cell - March 17th, 2019
- Stem Cell Questions - Florida Stem Cell - FAQs - February 2nd, 2019
- Stem Cell Procedure for Erectile Dysfunction - January 26th, 2019
- Stuart Florida Stem Cells | NovaGenix - January 18th, 2019
- Stem Cell Hair Treatment for Hair Loss | Stem Cell Hair Growth - January 3rd, 2019
- South Florida Stem Cell Center | Melvin M. Propis, M.D. - December 11th, 2018
- Florida Stem Cell Treatments - Regenerative Orthopedic ... - December 11th, 2018
- Florida - Stem Cells Transplant Institute - July 24th, 2018
- Stem cell research | UF Health, University of Florida Health - October 18th, 2017
- FDA: Serious Problems at Florida Stem Cell Clinic - WebMD - August 29th, 2017
- FDA Cracks Down On Stem-Cell Clinics Selling Unapproved Treatments - KRCB - August 29th, 2017
- US FDA steps up scrutiny of stem cell therapies - Reuters - August 29th, 2017
- Paralyzed After Pool Accident, Student Heads Back To College - News Talk Florida - August 29th, 2017
- SpaceX to Launch NASA Cargo, Try Rocket Landing Today: Watch It Live - Space.com - August 16th, 2017
- Dragon Splashes Down to Complete Resupply Mission - Space Daily - July 7th, 2017